Nov 15 (Reuters) - Entourage Health Corp ENTG.V :
* ENTOURAGE HEALTH - QTRLY TOTAL REVENUE OF $13.4 MILLION &
NET
REVENUE OF $10.1 MILLION VERSUS $14.9 MILLION AND $10.7 MILLION
FOR THE QUARTER ENDED SEPTEMBER 30, 2021
* ENTOURAGE HEALTH CORP - QTRLY GROSS PROFIT BEFORE CHANGES
IN
FAIR VALUE DECREASED BY $0.7 MILLION, OR -18%
* ENTOURAGE HEALTH CORP - THE WEIGHTED AVERAGE COST PER GRAM
FROM
CLONE TO HARVEST OF PLANTS ON HAND WAS $0.92 IN Q3 2022
* ENTOURAGE HEALTH-SIGNS THREE-YEAR SUPPLY AGREEMENT WITH
HEXO
CORP TO BUY BULK CANNABIS FOR EXPANDING RETAIL DISTRIBUTION AND
INCREASED MEDICAL OFFERINGS
* ENTOURAGE HEALTH-CO TO TRANSITION AWAY FROM CULTIVATION AS
IT
PHASES OUT GROWING FACILITIES, GENERATING ANNUALIZED COST
SAVINGS OF OVER $10 MILLION
Source text for Eikon: ID:
Further company coverage: ENTG.V